Defining Biological Subsets in Systemic Lupus Erythematosus: Progress Toward Personalized Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Defining Biological Subsets in Systemic Lupus Erythematosus: Progress Toward Personalized Therapy

Published:2017-01-25 Issue:2 Volume:31 Page:81-88
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Sinicato Nailú Angélica,Postal Mariana,Appenzeller Simone,Niewold Timothy B.^ORCID

Funder

National Institutes of Health

Alliance for Lupus Research

Lupus Research Institute

Mayo Foundation for Medical Education and Research

CureJM Foundation

The Myositis Foundation

Rheumatology Research Foundation

Lupus Foundation of Minnesota

Fundação Apoio À Pesquisa Estado São Paulo-Brasil

Conselho Nacional Pesquisa Desenvolvimento-Brasil

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40290-017-0178-6.pdf

Reference81 articles.

1. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev. 2010;9:A277–87.

2. Jimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003;25:3–12.

3. Gonzalez LA, Toloza SM, Alarcon GS. Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus. Rheum Dis Clin N Am. 2014;40:433–54, vii–viii.

4. Ghodke-Puranik Y, Niewold TB. Immunogenetics of systemic lupus erythematosus: a comprehensive review. J Autoimmun. 2015;64:125–36.

5. Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011;70:1752–7.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial;Clinical and Translational Science;2023-10-23

2. Efficacy and Safety of Rituximab Therapy for Lupus Nephritis Among SLE Female Patients; a Retrospective Hospital-Based Study;Open Access Rheumatology: Research and Reviews;2022-12

3. Discovery and mechanistic study of thiazole-4-acylsulfonamide derivatives as potent and orally active ChemR23 inhibitors with a long-acting effect in cynomolgus monkeys;Bioorganic & Medicinal Chemistry;2022-02

4. Alterations between Autophagy and Apoptosis in Alveolar Bone Mesenchymal Stem Cells under Orthodontic Force and Their Effects on Osteogenesis;Journal of Hard Tissue Biology;2022

5. Type I interferon antagonists in clinical development for lupus;Expert Opinion on Investigational Drugs;2020-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3